NGM BIOPHARMACEUTICALS INC(NASDAQ:NGM) stock News

NGM Latest News, Press Relases and Analysis

All

Press Releases

1 years ago - By: NGM Biopharmaceuticals, Inc.

NGM Bio Announces Closing of Tender Offer

1 years ago - By: NGM Biopharmaceuticals, Inc.

NGM Bio Announces Closing of Tender Offer

2 years ago - By: NGM Biopharmaceuticals, Inc.

NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting

2 years ago - By: Benzinga

Looking Into NGM Biopharmaceuticals's Recent Short Interest

2 years ago - By: Benzinga

Why NGM Biopharmaceuticals Stock Is Blasting Higher

2 years ago - By: NGM Biopharmaceuticals, Inc.

NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting

2 years ago - By: Kahn Swick & Foti, LLC

NGM BIOPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NGM Biopharmaceuticals, Inc. - NGM

2 years ago - By: NGM Biopharmaceuticals, Inc.

NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results

2 years ago - By: NGM Biopharmaceuticals, Inc.

NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results

2 years ago - By: Kahn Swick & Foti, LLC

NGM BIOPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NGM Biopharmaceuticals, Inc. - NGM

2 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether NGM Biopharmaceuticals, Inc. has obtained a Fair Price in its transaction with Atlas Neon

2 years ago - By: Halper Sadeh LLC

NGM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NGM Biopharmaceuticals, Inc. Is Fair to Shareholders

2 years ago - By: Brodsky & Smith LLC - Mentions: AGTI VZIO HRT

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, Inc. (NYSE – AGTI), NGM Biopharmaceuticals, Inc. (Nasdaq – NGM), VIZIO Holding Corp. (NYSE - VZIO), HireRight Holdings Corporation (NYSE – HRT)

2 years ago - By: Seeking Alpha

NGM Bio to go private in a $135M deal with Atlas Neon (NASDAQ:NGM)

2 years ago - By: NGM Biopharmaceuticals, Inc.

NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP

2 years ago - By: NGM Biopharmaceuticals, Inc.

NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP

2 years ago - By: NGM Biopharmaceuticals, Inc.

NGM Bio to Participate in the Cowen 44th Annual Health Care Conference

2 years ago - By: NGM Biopharmaceuticals, Inc.

NGM Bio to Participate in the Cowen 44th Annual Health Care Conference

2 years ago - By: NGM Biopharmaceuticals, Inc.

NGM Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference

2 years ago - By: NGM Biopharmaceuticals, Inc.

NGM Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference

2 years ago - By: Seeking Alpha - Mentions: MRK

NGM Biopharma stock on data for cancer therapy (NASDAQ:NGM)

2 years ago - By: NGM Biopharmaceuticals, Inc.

NGM Bio Announces New Clinical Data from Ongoing Trial of NGM707 in Advanced Solid Tumors and Outlines Evolved Strategy for Aldafermin and NGM120 to Focus on Rare Conditions with Significant Unmet Need

2 years ago - By: Seeking Alpha

NGM Biopharma stock jumps on take-private offer (NASDAQ:NGM)

2 years ago - By: NGM Biopharmaceuticals, Inc.

NGM Bio Presents Positive Phase 2b Results from the ALPINE 4 Trial of Aldafermin in Patients with Compensated Cirrhosis (F4) Due to NASH at AASLD The Liver Meeting®

NGM BIOPHARMACEUTICALS INC (NGM) Stock News

NGM Latest News, Press Relases and Analysis